@article{article, title  = {{The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Paracha N and Davies A and Latimer N and Parker C and Mealing S and Scott D and Padhiar A and Schulpher M and Wang Q}},

 doi = {{10.1200/jco.2013.31.15_suppl.636}},

 volume = {{31}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{636-636}},

 note = {{Accessed on 2024/12/22}}}